The monophasic combination preparation containing 30 micrograms ethinyl estradiol and
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …

Serum concentrations of gestagens were compared after single doses and after multiple
doses (steady-state conditions) of four widely used oral contraceptives containing …

The study was performed in 14 young women. The combination oral contraceptive
contained 75 μg gestodene (GSD) and 20 μg ethinyl estradiol (EE 2) per dosage unit. The …

The contraceptive efficacy, tolerance, and safety of a new monophasic oral contraceptive
that combines 75 mcg gestodene (delta-15-levonorgestrel) and 30 mcg ethinyl estradiol …

The monophasic low-dose contraceptive containing 30 μg of ethinyl estradiol and 75 μg of
gestodene has been tested in numerous clinical studies to determine contraceptive …

Results from two clinical pharmacokinetic studies are given. The first study was an
observational study in oral contraceptive users who took either a combination of gestodene …

Little is known about the pharmacokinetics of the two progestins levonorgestrel and
gestodene during long-term administration compared with single-dose pharmacokinetics …

Two triphasic oral contraceptives containing gestodene (GES)(a new progestogen) and
levonorgestrel (LNG) were compared with respect to contraceptive effect, cycle control …

An open label, non-comparative study was carried out in 22 women over a total of five
cycles. After an untreated cycle, oral administration of 20 μg ethinyl estradiol (EE) with 50 μg …

ABSTRACT A rapid and simple HPLC method for the determination of gestodene (GTD) and
ethinyl estradiol (ETE) in oral contraceptive formulations was developed and validated …